🎗️ Проект автоматически собирает и публикует онкологические новости из проверенных медицинских источников — 24/7, со ссылкой на первоисточник
Английские новости переводятся автоматически
Онкология

Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival

Treating individual metastatic tumors with highly focused radiation or surgery did not improve progression-free or overall survival for patients with oligometastatic breast cancer receiving first-line systemic therapy, according to results from the randomized NRG-BR002 clinical trial led by researchers at The…

Онкология

FDA approves Tukysa combination for HER2-positive breast cancer

The FDA has approved tucatinib plus trastuzumab and pertuzumab as front-line maintenance therapy for adults with unresectable, locally advanced or metastatic HER2-positive breast cancer following induction treatment. Tucatinib (Tukysa, Seagen), an oral tyrosine kinase inhibitor, had previously been approved in 2020 as…